These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 25771397)

  • 1. Immune profiling in patients with recurrent miscarriage.
    Kuon RJ; Strowitzki T; Sohn C; Daniel V; Toth B
    J Reprod Immunol; 2015 Apr; 108():136-41. PubMed ID: 25771397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progestagen therapy for recurrent miscarriage.
    Szekeres-Bartho J; Balasch J
    Hum Reprod Update; 2008; 14(1):27-35. PubMed ID: 18037606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defects in NKG2D ligand expression result in failed tolerance induction at the maternal-fetal interface: a possible cause for recurrent miscarriage.
    Mei B; Zhang SR; Chen YL; Wang CF
    Med Hypotheses; 2012 Oct; 79(4):465-7. PubMed ID: 22800801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-Pregnancy Levels of Peripheral Natural Killer Cells as Markers for Immunomodulatory Treatment in Patients with Recurrent Miscarriage.
    Kuon RJ; Müller F; Vomstein K; Weber M; Hudalla H; Rösner S; Strowitzki T; Markert U; Daniel V; Toth B
    Arch Immunol Ther Exp (Warsz); 2017 Aug; 65(4):339-346. PubMed ID: 28283683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrent miscarriage: current concepts in diagnosis and treatment.
    Toth B; Jeschke U; Rogenhofer N; Scholz C; Würfel W; Thaler CJ; Makrigiannakis A
    J Reprod Immunol; 2010 May; 85(1):25-32. PubMed ID: 20185181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunomodulators to treat recurrent miscarriage.
    Prins JR; Kieffer TE; Scherjon SA
    Eur J Obstet Gynecol Reprod Biol; 2014 Oct; 181():334-7. PubMed ID: 25156972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tim-3 signaling in peripheral NK cells promotes maternal-fetal immune tolerance and alleviates pregnancy loss.
    Li Y; Zhang J; Zhang D; Hong X; Tao Y; Wang S; Xu Y; Piao H; Yin W; Yu M; Zhang Y; Fu Q; Li D; Chang X; Du M
    Sci Signal; 2017 Sep; 10(498):. PubMed ID: 28951537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The presence of HLA-antibodies in recurrent miscarriage patients is associated with a reduced chance of a live birth.
    Nielsen HS; Witvliet MD; Steffensen R; Haasnoot GW; Goulmy E; Christiansen OB; Claas F
    J Reprod Immunol; 2010 Dec; 87(1-2):67-73. PubMed ID: 20605049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent miscarriage is a useful and valid clinical concept.
    Christiansen OB
    Acta Obstet Gynecol Scand; 2014 Sep; 93(9):852-7. PubMed ID: 25040853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What is wrong with the regulatory T cells and foetomaternal tolerance in women with recurrent miscarriages?
    Craenmehr MH; Heidt S; Eikmans M; Claas FH
    HLA; 2016 Feb; 87(2):69-78. PubMed ID: 26841054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-visualized pregnancy losses are prognostically important for unexplained recurrent miscarriage.
    Kolte AM; van Oppenraaij RH; Quenby S; Farquharson RG; Stephenson M; Goddijn M; Christiansen OB;
    Hum Reprod; 2014 May; 29(5):931-7. PubMed ID: 24603132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is recurrent miscarriage a useful clinical concept?
    Vlaanderen W
    Acta Obstet Gynecol Scand; 2014 Sep; 93(9):848-51. PubMed ID: 25040703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defect in lipid rafts results in failed tolerance induction at the maternal-fetal interface: a possible cause for the recurrent spontaneous abortion.
    Chen LJ; Zhou H; Zou L
    Med Hypotheses; 2008 Aug; 71(2):275-8. PubMed ID: 18417296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and treatment of recurrent miscarriage associated with immunologic disorders: Is paternal lymphocyte immunization a relic of the past?
    Takeshita T
    J Nippon Med Sch; 2004 Oct; 71(5):308-13. PubMed ID: 15514447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced expression of IL-6 and IL-1alpha mRNAs in secretory phase endometrium of women with recurrent miscarriage.
    Jasper MJ; Tremellen KP; Robertson SA
    J Reprod Immunol; 2007 Feb; 73(1):74-84. PubMed ID: 17034864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The possible role of classical human leukocyte antigens in recurrent miscarriage.
    Christiansen OB
    Am J Reprod Immunol; 1999 Aug; 42(2):110-5. PubMed ID: 10476693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent miscarriage: a review of current concepts, immune mechanisms, and results of treatment.
    Carp HJ; Toder V; Mashiach S; Nebel L; Serr DM
    Obstet Gynecol Surv; 1990 Oct; 45(10):657-69. PubMed ID: 2234701
    [No Abstract]   [Full Text] [Related]  

  • 18. [Habitual abortion. A review of etiology, diagnosis and treatment with emphasis on immunonological factors].
    Christiansen OB; Knudsen HJ; Rasmussen KL
    Ugeskr Laeger; 1997 Aug; 159(32):4841-5. PubMed ID: 9273755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The basis and value of currently used immunomodulatory therapies in recurrent miscarriage.
    Bansal AS; Bajardeen B; Thum MY
    J Reprod Immunol; 2012 Jan; 93(1):41-51. PubMed ID: 22196105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The maternal-fetal interaction: some controversies and solutions.
    Adinolfi M
    Exp Clin Immunogenet; 1993; 10(2):103-17. PubMed ID: 8251179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.